- Home
- CZFS vs MREO Comparison
CZFS vs MREO Comparison
Compare CZFS & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZFS
- MREO
- Stock Information
- Founded
- CZFS 1984
- MREO 2015
- Country
- CZFS United States
- MREO United Kingdom
- Employees
- CZFS N/A
- MREO N/A
- Industry
- CZFS Major Banks
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- CZFS Finance
- MREO Health Care
- Exchange
- CZFS Nasdaq
- MREO Nasdaq
- Market Cap
- CZFS 275.0M
- MREO 326.1M
- IPO Year
- CZFS N/A
- MREO N/A
- Fundamental
- Price
- CZFS $57.84
- MREO $2.01
- Analyst Decision
- CZFS
- MREO Strong Buy
- Analyst Count
- CZFS 0
- MREO 5
- Target Price
- CZFS N/A
- MREO $7.40
- AVG Volume (30 Days)
- CZFS 9.6K
- MREO 1.2M
- Earning Date
- CZFS 10-29-2025
- MREO 11-11-2025
- Dividend Yield
- CZFS 3.47%
- MREO N/A
- EPS Growth
- CZFS 15.37
- MREO N/A
- EPS
- CZFS 6.58
- MREO N/A
- Revenue
- CZFS $104,184,000.00
- MREO $500,000.00
- Revenue This Year
- CZFS N/A
- MREO N/A
- Revenue Next Year
- CZFS $5.45
- MREO $72.16
- P/E Ratio
- CZFS $8.67
- MREO N/A
- Revenue Growth
- CZFS 6.11
- MREO N/A
- 52 Week Low
- CZFS $49.99
- MREO $1.47
- 52 Week High
- CZFS $75.40
- MREO $4.72
- Technical
- Relative Strength Index (RSI)
- CZFS 40.40
- MREO 62.65
- Support Level
- CZFS $56.58
- MREO $1.94
- Resistance Level
- CZFS $60.75
- MREO $2.12
- Average True Range (ATR)
- CZFS 1.95
- MREO 0.11
- MACD
- CZFS -0.73
- MREO 0.02
- Stochastic Oscillator
- CZFS 15.00
- MREO 73.49
About CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).